Cornercap Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,454
Closed -$410K 321
2024
Q4
$410K Hold
4,454
0.13% 267
2024
Q3
$414K Sell
4,454
-4,143
-48% -$359K 0.12% 291
2024
Q2
$707K Sell
8,597
-86
-1% -$6.32K 0.12% 315
2024
Q1
$576K Buy
+8,683
New +$536K 0.09% 375
2021
Q4
Sell
-19,726
Closed -$1.05M 574
2021
Q3
$1.05M Buy
+19,726
New +$1.11M 0.12% 324

Other funds holding LMAT

Cornercap Investment Counsel's LMAT Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 4,454 shares — an estimated $410K sold.

Cornercap Investment Counsel first reported a position in LMAT in Q3 2021 and held it in 5 quarters. The position peaked at $1.05M in Q3 2021. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 4,454 LeMaitre Vascular shares in Q1 2025, an estimated $410K.
  • Cornercap Investment Counsel first reported a position in LeMaitre Vascular in Q3 2021 and held it in 5 quarters.
  • Cornercap Investment Counsel's LeMaitre Vascular position peaked at $1.05M in Q3 2021.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.